An academic-marketing collaborative to promote depression care: A tale of two cultures

Patient Education and Counseling

Volumn 90, Issue 3, 2013, Pages 411-419

  Kravitz, Richard L ^a,d   Epstein, Ronald M ^b,c   Bell, Robert A ^d   Rochlen, Aaron B ^e   Duberstein, Paul ^c   Riby, Caroline H ^f,g   Caccamo, Anthony F ^f   Slee, Christina K ^d   Cipri, Camille S ^d   Paterniti, Debora A ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^f Roberts Communications   (United States)

^g SYRACUSE UNIVERSITY   (United States)

Author keywords

Advertising; Depression; Health communication; Patient activation; Social marketing

Indexed keywords

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DOCTOR PATIENT RELATION; FEMALE; HEALTH CARE QUALITY; HUMAN; INTERDISCIPLINARY EDUCATION; MALE; MARKETING; MEDICAL INFORMATION; ORGANIZATIONAL DOWNSIZING; ORGANIZATIONAL EFFICIENCY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT EDUCATION; PHYSICIAN ATTITUDE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; PROFESSIONAL KNOWLEDGE; SEX DIFFERENCE;

COMMUNICATION; CULTURE; DEPRESSION; HEALTH PROMOTION; HEALTH SERVICES RESEARCH; HUMANS; MARKETING OF HEALTH SERVICES; PATIENT EDUCATION AS TOPIC; PRIMARY HEALTH CARE;

EID: 84873419040     PISSN: 07383991     EISSN: 18735134     Source Type: Journal    
DOI: 10.1016/j.pec.2011.07.003     Document Type: Article

References (39)

1. Cegala D.J., Street R.L., Clinch C.R. The impact of patient participation on physicians' information provision during a primary care medical interview. Health Commun 2007, 21:177-185.
2. Greenfield S., Kaplan S., Ware J.E. Expanding patient involvement in care. Effects on patient outcomes. Ann Intern Med 1985, 102:520-528.
3. Greenfield S., Kaplan S.H., Ware J.E., Yano E.M., Frank H.J. Patients' participation in medical care: effects on blood sugar control and quality of life in diabetes. J Gen Intern Med 1988, 3:448-457.
4. Gilbody S., Wilson P., Watt I. Benefits and harms of direct to consumer advertising: a systematic review. Qual Saf Health Care 2005, 14:246-250.
5. Wilkes M.S., Bell R.A., Kravitz R.L. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Aff (Millwood) 2000, 19:110-128.
6. Bell R.A., Kravitz R.L., Wilkes M.S. Direct-to-consumer prescription drug advertising and the public. J Gen Intern Med 1999, 14:651-657.
7. Mintzes B., Barer M.L., Kravitz R.L., Bassett K., Lexchin J., Kazanjian A., et al. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. Can Med Assoc J 2003, 169:405-412.
8. Mintzes B., Barer M.L., Kravitz R.L., Kazanjian A., Bassett K., Lexchin J., et al. Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey. Brit Med J 2002, 324:278-279.
9. Frosch D.L., Grande D., Tarn D.M., Kravitz R.L. A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising. Am J Public Health 2010, 100:24-32.
10. Frosch D.L., Krueger P.M., Hornik R.C., Cronholm P.F., Barg F.K. Creating demand for prescription drugs: a content analysis of television direct-to-consumer advertising. Ann Fam Med 2007, 5:6.
11. Roth M.S. Media and message effects on DTC prescription drug print advertising awareness. J Advert Res 2003, 43:180-193.
12. Harker M., Harker D. Direct-to-consumer-advertising of prescription medicines: a theoretical approach to understanding. Leadersh Health Serv (Bradf Engl) 2007, 20:76-84.
13. Pinto M.B. On the nature and properties of appeals used in direct-to-consumer advertising of prescription drugs. Psychol Rep 2000, 86:597.
14. Moons W.G., Mackie D.M., Garcia-Marques T. The impact of repetition-induced familiarity on agreement with weak and strong arguments. J Pers Soc Psychol 2009, 96:32-44.
15. Kravitz R.L., Bell R.A. Direct-to-consumer advertising of prescription drugs: balancing benefits and risks, and a way forward. Clin Pharmacol Ther 2007, 82:360-362.
16. Berndt E.R. To inform or persuade? Direct-to-consumer advertising of prescription drugs. N Engl J Med 2005, 352:325-328.
17. Kravitz R.L., Epstein R.M., Feldman M.D., Franz C.E., Azari R., Wilkes M.S., et al. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. J Amer Med Assoc 2005, 293:1995-2002.
18. Mintzes B., Morgan S., Wright J.M. Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale. PLoS One 2009, 4:e5699.
19. Abel G.A., Lee S.J., Weeks J.C. Direct-to-consumer advertising in oncology: a content analysis of print media. J Clin Oncol 2007, 25:1267-1271.
20. Healy D. Have drug companies hyped social anxiety disorder to increase sales. Yes: marketing hinders discovery of long-term solutions. West J Med 2001, 175:364.
21. Donohue J.M., Berndt E.R., Rosenthal M., Epstein A.M., Frank R.G. Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Med Care 2004, 42:1176-1185.
22. Block A.E. Costs and benefits of direct-to-consumer advertising: the case of depression. Pharmacoeconomics 2007, 25:511-521.
23. Schulberg H.C., Katon W., Simon G.E., Rush A.J. Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines. Arch Gen Psychiatry 1998, 55:1121-1127.
24. Epstein R.M., Duberstein P.R., Feldman M.D., Rochlen A.B., Bell R.A., Kravitz R.L., et al. I didn't know what was wrong:" how people with undiagnosed depression recognize, name and explain their distress. J Gen Intern Med 2010, 25:954-961.
25. Donohue J.M., Berndt E.R. Effects of direct-to-consumer advertising on medication choice: the case of antidepressants. J Public Policy Mark 2004, 23:115-127.
26. Kravitz R.L., Paterniti D.A., Epstein R.M., Rochlen A.B., Bell R.A., Cipri C., et al. Relational barriers to depression help-seeking in primary care. Patient Educ Couns 2011, 82:207-213.
27. Morgan D., Krueger R.A. The focus group kit 1997, Sage Publications, Newberry Park.
28. Denzin N.K., Lincoln Y.S. Handbook of qualitative research 2000, Sage Publications, Thousand Oaks, CA. 2nd ed.
29. Rochlen A.B., Paterniti D.A., Epstein R.M., Duberstein P., Willeford L., Kravitz R.L. Barriers in diagnosing and treating men with depression: a focus group report. Am J Mens Health 2010, 4:167-175.
30. Bell R.A., Paterniti D.A., Azari R., Duberstein P.R., Epstein R.M., Rochlen A.B., et al. Encouraging patients with depressive symptoms to seek care: a mixed methods approach to message development. Patient Educ Couns 2010, 78:198-205.
31. Fernandez Y.G.E., Franks P., Jerant A., Bell R.A., Kravitz R.L. Depression treatment preferences of Hispanic individuals: exploring the influence of ethnicity, language, and explanatory models. J Am Board Fam Med 2011, 24:39-50.
32. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001, 16:606-613.
33. Warden D., Rush A.J., Trivedi M.H., Fava M., Wisniewski S.R. The STAR*D project results: a comprehensive review of findings. Curr Psychiatry Rep 2007, 9:449-459.
34. Cepoiu M., McCusker J., Cole M.G., Sewitch M., Belzile E., Ciampi A. Recognition of depression by non-psychiatric physicians-A systematic literature review and meta-analysis. J Gen Intern Med 2008, 23:25-36.
35. Rodondi P.Y., Maillefer J., Suardi F., Rodondi N., Cornuz J., Vannotti M. Physician response to "By-the-Way" syndrome in primary care. J Gen Intern Med 2009, 24:739-741.
36. Siegel M. Mass media antismoking campaigns: a powerful tool for health promotion. Ann Intern Med 1998, 129:128.
37. Andreasen A.R. Marketing social marketing in the social change marketplace. J Public Policy Mark 2002, 21:3-13.
38. Bartholomew L.K., Parcel G.S., Kok G., Gottlieb N.H. Planning health promotion programs: an intervention mapping approach 2006, Jossey-Bass.
39. Zatzick D.F., Koepsell T., Rivara F.P. Using target population specification, effect size, and reach to estimate and compare the population impact of two PTSD preventive interventions. Psychiatry 2009, 72:346-359.